Shaanxi Panlong Pharmaceutical Group Limited By Share Balance Sheet Health
Financial Health criteria checks 5/6
Shaanxi Panlong Pharmaceutical Group Limited By Share has a total shareholder equity of CN¥1.6B and total debt of CN¥149.5M, which brings its debt-to-equity ratio to 9.3%. Its total assets and total liabilities are CN¥2.3B and CN¥647.9M respectively. Shaanxi Panlong Pharmaceutical Group Limited By Share's EBIT is CN¥104.4M making its interest coverage ratio -4.6. It has cash and short-term investments of CN¥1.2B.
Key information
9.3%
Debt to equity ratio
CN¥149.50m
Debt
| Interest coverage ratio | -4.6x |
| Cash | CN¥1.16b |
| Equity | CN¥1.61b |
| Total liabilities | CN¥647.90m |
| Total assets | CN¥2.26b |
Recent financial health updates
No updates
Recent updates
There Is A Reason Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's (SZSE:002864) Price Is Undemanding
Sep 30
Shaanxi Panlong Pharmaceutical Group Limited By Share's (SZSE:002864) Shareholders Will Receive A Bigger Dividend Than Last Year
May 31We Think That There Are Some Issues For Shaanxi Panlong Pharmaceutical Group Limited By Share (SZSE:002864) Beyond Its Promising Earnings
May 02Earnings Not Telling The Story For Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SZSE:002864) After Shares Rise 32%
Mar 06Financial Position Analysis
Short Term Liabilities: 002864's short term assets (CN¥1.8B) exceed its short term liabilities (CN¥447.4M).
Long Term Liabilities: 002864's short term assets (CN¥1.8B) exceed its long term liabilities (CN¥200.5M).
Debt to Equity History and Analysis
Debt Level: 002864 has more cash than its total debt.
Reducing Debt: 002864's debt to equity ratio has increased from 0% to 9.3% over the past 5 years.
Debt Coverage: 002864's debt is well covered by operating cash flow (100.4%).
Interest Coverage: 002864 earns more interest than it pays, so coverage of interest payments is not a concern.